Video Library

CAR T-cell therapy is a type of specialized immunotherapy that uses the patient's own modified T-cells to fight cancer. It is approved to treat certain blood cancers like lymphoma, leukemia, and multiple myeloma.

Acute myeloid leukemia (AML) is a rare disease that is seen most often in older adults, although it can occur in younger people as well. This webinar discusses the symptoms of AML, how it is diagnosed, risk factors for developing AML, and current treatment options.

Nancy Dana underwent a stem cell transplant after being diagnosed with Mantle Cell Lymphoma. In this video, she shares 15 helpful lessons she learned about preparing for a transplant, making the hospital stay as comfortable as possible, and strategies for recovering and approaching life after transplant.

Strategies astronauts use to stay fit during space flight can help bone marrow/stem cell transplant and CAR T-cell recipients.

Late effects after an allogeneic transplant (a transplant using donor cells) can affect the physical, psychological, and social well-being of survivors. Dr. Hamilton sheds light on the most common long-term effects and how they can best be managed to minimize complications. She also stresses the importance of ongoing survivorship care to ensure that survivors can live life to the fullest.

In the years after having a transplant using your own cells (autologous transplant), complications can develop. This presentation describes possible late complications, risk factors for each complication, ways that you can help minimize the risks, and strategies for managing any complications that do occur.

CAR T-cell therapy is an exciting second-line option for patients living with relapsed multiple myeloma. In this presentation, Dr. Ahmed reviews each step in the CAR T process and discusses a number of studies that support its use. Potential side effects are reviewed, and exciting future trends are discussed.

La terapia de Células CAR-T es una nueva terapia para pacientes con mieloma múltiple. Esta presentación explica qué es la terapia de Células CAR-T, cuál es su eficacia para los pacientes con mieloma y los posibles efectos secundarios.

CAR T therapy (chimeric antigen receptor therapy) is a new treatment strategy that has been shown to improve patient outcomes. In this lecture, Dr. William reviews the steps involved, including T-cell collection, lymphodepleting chemotherapy, reinfusion of T-cells, and follow-up care. Potential side effects and their treatments are discussed as wel

Advanced age has traditionally been seen as prohibitive for treatments like stem cell transplants and CAR T therapy. This presentation reviews evidence that overall fitness is a crucial factor in reducing non-relapse mortality and that otherwise healthy elderly patients can have successful outcomes after transplant and CAR T-cell therapy.

La terapia de células CAR T es un tratamiento nuevo para pacientes que tienen ciertos tipos de linfoma no Hodgkin. Conozca lo que implica someterse a una terapia de células CAR T, quién es un buen candidato y los posibles resultados.

Multiple studies have shown that most patients who receive chimeric antigen receptor (CAR) T-cell therapy report a good quality of life long-term. Learn how CAR T-cell therapy is performed and its short-term and long-term effects on patients and caregivers. Discover key differences between CAR T-cell, stem cell transplant and other and chemotherapy treatments.